BioMarin Pharmaceutical Inc. (BMRN)
NASDAQ·Healthcare·Biotechnology
$64.56
-0.81%
Mkt Cap $12.69B
Analyst Ratings
Buy
15
Hold
6
Sell
0
Price Target (66 analysts)
$89.21
Range $50.00 – $120.00
Implied Upside
+38.2%
Consensus $89.21 vs current $64.56
NASDAQ·Healthcare·Biotechnology
$64.56
-0.81%
Mkt Cap $12.69B
Buy
15
Hold
6
Sell
0
Price Target (66 analysts)
$89.21
Range $50.00 – $120.00
+38.2%
Consensus $89.21 vs current $64.56